Venlafaxine clinical trials
Also written Effexor.
Includes 9 studies of Venlafaxine Hydrochloride Extended Release.
How each study uses venlafaxine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the venlafaxine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 28 Dec 1993 · EFFEXOR · NDA 020151 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
120 studies that test it; most in 2002 (11)
| Year | Studies |
|---|---|
| 1995 | 1 |
| 1996 | 1 |
| 1999 | 2 |
| 2000 | 2 |
| 2001 | 6 |
| 2002 | 11 |
| 2003 | 5 |
| 2004 | 11 |
| 2005 | 7 |
| 2006 | 6 |
| 2007 | 6 |
| 2008 | 7 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 7 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 38 · Other 84
Wyeth is now a wholly owned subsidiary of Pfizer (16) · New York State Psychiatric Institute (6) · University of California, Los Angeles (5) · Teva Pharmaceuticals USA (5) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (4) · Eli Lilly and Company (4) · Massachusetts General Hospital (3) · Mayo Clinic (3)
Often tested with
Tested in the same studies.
Sertraline (14) · Escitalopram (8) · Citalopram (7) · Duloxetine (7) · Paroxetine (6) · Fluoxetine (5) · Bupropion (4) · Aripiprazole (3)
Related medicines
As reviewed, each with the page that says it.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test venlafaxine.
- Jun 2027The Efficacy and Safety of Pregabalin Combined With Venlafaxine in Patients With FibromyalgiaNot applicable · Beijing Tiantan Hospital
- Jun 2027Pragmatic Trial of Obsessive-compulsive DisorderPhase 2 · Shanghai Mental Health Center
Studies
Open first, then newest update. How each study uses venlafaxine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 122
- The Efficacy and Safety of Pregabalin Combined With Venlafaxine in Patients With FibromyalgiaRecruitingNot applicableBeijing Tiantan HospitalNCT07186751Written as Pregabalin with venlafaxineHow we know
- Venlafaxine for Non-specific Low Back PainNot yet recruitingNot applicableBeijing Tiantan HospitalNCT07737158Written as Venlafaxine groupHow we know
- Venlafaxine as Adjunct Therapy in Rheumatoid ArthritisNot yet recruitingPhase 2Ain Shams UniversityNCT07497282Written as venlafaxine extended-release (XR)How we know
- The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.RecruitingPhase 3Dr. Inge WinterNCT05973786Written as VenlafaxineHow we know
- Pragmatic Trial of Obsessive-compulsive DisorderRecruitingPhase 2Shanghai Mental Health CenterNCT04539951Written as VenlafaxineHow we know
- REDucing Hot FLASHes in Women Using Endocrine Therapy.RecruitingPhase 3Reinier de Graaf GroepNCT06106529Written as VenlafaxineHow we know
- The Role of Negr1 In Modulating Neuroplasticity in Major Depression (RONIN)RecruitingPhase 4Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoNCT06131268Written as VenlafaxineHow we know
- Venlafaxine for Postoperative Pain of Laparoscopic CholecystectomyNot yet recruitingPhase 1/2Mansoura UniversityNCT05884268Written as VenlafaxineHow we know
- Preventive Approach Using VenlafaxineRecruitingPhase 4Mit Ghamr Oncology CenterNCT05875610Written as Venlafaxine 75 MGHow we know
- Effect of Venlafaxine Versus Dosulepin in Pain Predominant Somatic Symptom DisorderCompletedPhase 4All India Institute of Medical Sciences, BhubaneswarNCT06803485Written as VenlafaxineHow we know
- The Use of Venlafaxine in Reducing Pain in Primary Total Knee ReplacementCompletedPhase 4University of California, San FranciscoNCT05023278Written as Venlafaxine 37.5 MGHow we know
- Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment FailureTerminatedPhase 3Dr. Inge WinterNCT05603104Written as VenlafaxineHow we know
- Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRDCompletedPhase 4Massachusetts General HospitalNCT02977299Written as Venlafaxine XRHow we know
- Pharmacological Treatment Targeting Endotypic Traits of Obstructive Sleep ApneaCompletedPhase 4China Medical University HospitalNCT06295562Written as Venlafaxine 37.5mgHow we know
- Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation TherapyCompletedPhase 2Roswell Park Cancer InstituteNCT03574792Written as VenlafaxineHow we know
- Physiologic Monitoring of Antidepressant ResponseCompletedPhase 4University of California, Los AngelesNCT00792168Written as venlafaxine (Effexor)How we know
- Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder (MDD) (DEPARRESTCLIN)CompletedPhase 4Institut National de la Santé Et de la Recherche Médicale, FranceNCT02051413Written as Venlafaxine extended releaseHow we know
- Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast CancerSuspendedPhase 3New York State Psychiatric InstituteNCT04973930Written as Venlafaxine HCl ERHow we know
- Mood Disorders in Head and Neck Cancer PatientsWithdrawnPhase 4University of Alabama at BirminghamNCT04977271Written as VenlafaxineHow we know
- Venlafaxine and Hypnosis or Focused Attention in Treating Patients with Hot FlashesCompletedNot applicableMayo ClinicNCT01000623Written as venlafaxineHow we know
See all 122 studies that test venlafaxine →
Given beside what is tested · 19 — venlafaxine is usual care or a partner of the new treatment
- A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant DepressionCompletedPhase 3Janssen Research & Development, LLCNCT02493868Written as Venlafaxine Extended Release (XR) (Oral Antidepressant)How we know
- A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant DepressionCompletedPhase 3Janssen Research & Development, LLCNCT02422186Written as Venlafaxine Extended Release (XR) (New Antidepressant)How we know
- A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionCompletedPhase 3Janssen Research & Development, LLCNCT03434041Written as Venlafaxine Extended Release (XR) (Oral Antidepressant)How we know
- A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionCompletedPhase 3Janssen Research & Development, LLCNCT02417064Written as Venlafaxine Extended Release (XR) (Oral Antidepressant)How we know
- A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant DepressionCompletedPhase 3Janssen Research & Development, LLCNCT02497287Written as Venlafaxine Extended Release (XR) (Oral Antidepressant)How we know
- A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionCompletedPhase 3Janssen Research & Development, LLCNCT02418585Written as Venlafaxine Extended Release (XR) (Oral Antidepressant)How we know
- Accurate Clinical Study of Medication in Patients With Depression Via Pharmacogenomics (PGx) and Therapeutic Drug Monitoring (TDM) of VenlafaxineStatus unknownPhase 4Xijing HospitalNCT04207385Written as VenlafaxineHow we know
- Buprenorphine Used With Treatment Resistant Depression in Older AdultsCompletedPhase 1/2Washington University School of MedicineNCT02181231Written as venlafaxine XRHow we know
- Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)CompletedPhase 3Otsuka Pharmaceutical Development & Commercialization, Inc.NCT01360866Written as Venlafaxine XRHow we know
- Incomplete Response in Late-Life Depression: Getting to Remission With BuprenorphineCompletedPhase 1/2Centre for Addiction and Mental HealthNCT02263248Written as venlafaxineHow we know
- A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and ExerciseCompletedPhase 4Kirk Erickson, PhDNCT02407704Written as Venlafaxine XRHow we know
- ADAPT: Addressing Depression and Pain TogetherCompletedPhase 4University of PittsburghNCT01124188Written as Higher-dose venlafaxineHow we know
- Combined Treatment for Generalized Anxiety Disorder (GAD)CompletedPhase 2University of PennsylvaniaNCT00620776Written as Venlafaxine XRHow we know
- Venlafaxine Augmentation in Treatment Resistant DepressionCompletedPhase 4Max-Planck-Institute of PsychiatryNCT00253266Written as VenlafaxineHow we know
- Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With DepressionTerminatedPhase 4Novartis PharmaceuticalsNCT01436643Written as VenlafaxineHow we know
- Interpersonal Psychotherapy for Treatment Resistant DepressionStatus unknownNot applicableHospital de Clinicas de Porto AlegreNCT01896349Written as VenlafaxineHow we know
- Antidepressant Medication Plus Donepezil for Treating Late-life DepressionCompletedPhase 4University of PittsburghNCT00177671Written as VenlafaxineHow we know
- Randomised Controlled Trial of Electroconvulsive Therapy (ECT) in Relapse Prevention of DepressionCompletedPhase 4Örebro County CouncilNCT00627887Written as venlafaxineHow we know
- A Study of Eszopiclone Co-administered With Venlafaxine in Subjects With Major Depressive Disorder and InsomniaCompletedPhase 3Sumitomo Pharma America, Inc.NCT00435279Written as VenlafaxineHow we know
As the comparator · 16 — what is tested is compared with venlafaxine
- A Safety and Efficacy Study of JNJ26489112 in Patients With Treatment-Resistant Major Depressive DisorderTerminatedPhase 2Janssen Research & Development, LLCNCT01114698Written as Venlafaxine XRHow we know
- Vortioxetine as a Novel Anti-depressant With Improvement in Cognitive AbilitiesStatus unknownPhase 3Scotmann PharmaceuticalsNCT05104918Written as VenlafaxineHow we know
- A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major DepressionCompletedPhase 4Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00644982Written as venlafaxine XRHow we know
- Acupuncture for Prophylaxis of Vestibular MigraineStatus unknownNot applicableAffiliated Hospital of Jiaxing UniversityNCT04664088Written as VenlafaxineHow we know
- Bioequivalence Study of Venlafaxine Hydrochloride Sustained-Release Capsules in Chinese Healthy VolunteersStatus unknownNot applicableBeijing Tongren HospitalNCT04229602Written as EFEXOR® XRHow we know
- Prolonging Remission in Depressed Elderly (PRIDE)CompletedPhase 4Icahn School of Medicine at Mount SinaiNCT01028508Written as lithium and VenlafaxineHow we know
- Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six WeeksCompletedPhase 3University Hospital, GrenobleNCT01557712Written as VenlafaxineHow we know
- Trazodone Once a Day in Major Depression DisorderCompletedPhase 3Aziende Chimiche Riunite Angelini Francesco S.p.ANCT02086929Written as VenlafaxineHow we know
- Effect of Antidepressants on the Treatment for Korean Major Depressive Disorder PatientsTerminatedPhase 4Ministry of Health & Welfare, KoreaNCT00926835Written as Venlafaxine XRHow we know
- Study of Vortioxetine (Lu AA21004) in Major Depressive Disorder in Asian CountriesCompletedPhase 3H. Lundbeck A/SNCT01571453Written as Venlafaxine extended releaseHow we know
- A Study Of New Medicine (GSK 372475) For The Treatment Of DepressionCompletedPhase 2GlaxoSmithKlineNCT00448058Written as venlafaxineHow we know
- Randomised Placebo-controlled Venlafaxine-referenced Study of Efficacy and Safety of 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in AdultsCompletedPhase 2H. Lundbeck A/SNCT00839423Written as Venlafaxine XLHow we know
- Algorithm Guided Treatment Strategies for Major Depressive DisorderStatus unknownPhase 4Shanghai Mental Health CenterNCT01764867Written as VenlafaxineHow we know
- Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)TerminatedPhase 2National Center for Complementary and Integrative Health (NCCIH)NCT00083980Written as Venlafaxine ERHow we know
- A Safety, Efficacy and Tolerability Study of SEP-225289CompletedPhase 2Sumitomo Pharma America, Inc.NCT00584974Written as VenlafaxineHow we know
- Efficacy and Safety of Lu AA34893 in Patients With Major Depressive DisorderTerminatedPhase 2H. Lundbeck A/SNCT00766870Written as Venlafaxine extended releaseHow we know
What changed recently
From the registry's own updates since Oct 20, 2026.
Results posted1
- The Use of Venlafaxine in Reducing Pain in Primary Total Knee ReplacementNov 10, 2026NCT05023278
Stopped1
Codes
What other systems call venlafaxine · ClinicalTrials.gg INT006595
- MeSH (NLM) D000069470Venlafaxine HydrochlorideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) GRZ5RCB1QGVENLAFAXINEConfirmed FDA, NLM, Wikidata
- RxNorm 39786Confirmed FDA, Wikidata
- Wikidata Q898407venlafaxineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1278VenlafaxineOne source FDA
- DrugBank DB00285One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069470 | Venlafaxine Hydrochloride | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | GRZ5RCB1QG | VENLAFAXINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 39786 | — | Confirmed FDA, Wikidata |
| Wikidata | Q898407 | venlafaxine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1278 | Venlafaxine | One source FDA |
| DrugBank | DB00285 | — | One source Wikidata |
Also registered as venlafaxine hydrochloride (UNII 7D7RX5A8MO · RxNorm 235988).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.